Target intelligence / Profile preview

SUGT1 divergent transcript (SUGT1-DT)

Target
SUGT1-DT
Molecular classification
Other
01

Overview

SUGT1 divergent transcript (SUGT1-DT) is annotated in genomic databases as a non-coding transcript associated with the SUGT1 gene, but there is no direct evidence in the literature that it is a therapeutic target such as a receptor, enzyme, transporter, or regulator involved in drug actions or disease mechanisms. SUGT1-DT is identified by NCBI Gene 116435302 and Ensembl ENSG00000273723, but its molecular function, biological role, or involvement in disease remains unknown based on currently available public data. If the intent was to refer to SUGT1, a protein-coding gene with disease relevance, that would be a different target with more available functional and disease association data. Therefore, the entry as a target is likely incorrect, as SUGT1-DT is not the established therapeutic target, and its biological or pathological significance is not established in the scientific literature.

Other names
SUGT1 divergent transcriptSUGT1-DT
02

Biological functions

Unknown
03

Disease associations

Other

Beyond the preview

Go deeper on SUGT1 divergent transcript (SUGT1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUGT1 divergent transcript (SUGT1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call